Colgate posts 12% sales growth, ₹343 Cr PAT; adjusted profit +11% as premiumisation drives a Q1 beat

Colgate-Palmolive (India) opened FY27 with standalone net sales up ~12% YoY to ₹1,591 Cr (revenue from operations ₹1,603 Cr including other operating income), comfortably beating the ~7–9% growth the Street had penciled in for the quarter and marking a clear acceleration on Q4 FY26's 9%. Reported net profit rose to ₹343 Cr from ₹321 Cr a year ago — a modest +7% headline — but on an adjusted basis, stripping the inverted-duty-structure GST charge and ₹3.3 Cr of organisational-restructuring severance, management pegs profit growth at +11% YoY, broadly in step with the topline. Growth was broad-based and volume-led: management cited high-single-digit toothpaste volume growth powered by the premium portfolio alongside a steady core, confirming the premiumisation-led thesis it set out on the Q4 concall.

The margin story is a deliberate trade-off rather than a squeeze. Gross margin expanded ~110 bps YoY to 69.7% on Funding-the-Growth cost savings, but the company ploughed that gain straight back into brand building — advertising spend jumped ~34% YoY to ₹252 Cr — so net margin eased to ~21.1% of total income from ~22.1% a year earlier (and 21.9% in Q4). In other words, the compression sits on the A&P line by choice, not on the cost base. PAT margin on net sales (~21.6%) still ran well above the 18–19% the pre-result preview had flagged, so the print beat our bar on both topline and profitability, and resolves the watch items we set: 8–9% sales growth was exceeded at 12%, and margins held with a gross-margin surprise to the upside.

The stock went into the print at ₹2,146.2, up 7.4% over the past month of trading.

For context: revenue is at a 6-quarter high.

EPS ₹12.61 vs ₹11.79 YoY — exceptional item ₹3.3 Cr (Q1 severance). Quarter unaudited, limited-reviewed.

Sequentially the quarter was near-flat — revenue +0.5% and PAT −2.9% versus Q4 FY26's ₹353 Cr — which is the seasonally correct read for FMCG and not the story; YoY is where the momentum shows. Management's tone stays confident: it reaffirmed the premiumisation and innovation agenda (MaxFresh Berry Blast, Total Active Prevention toothbrush launches) and framed calibrated pricing plus cost savings as the levers to protect margins against commodity-price volatility. The company gives no formal quantified guidance, but the qualitative outlook it offered last quarter — balanced volume-and-price growth led by premium — was confirmed by this print rather than contradicted.